About ProPhase Labs, Inc.
https://www.prophaselabs.comProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products.

CEO
Ted William Karkus
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-12-22 | Reverse | 1:10 |
| 1997-01-23 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : D+
Price Target
Institutional Ownership

SYKON CAPITAL LLC
Shares:644.79K
Value:$116.58K

VANGUARD GROUP INC
Shares:531.92K
Value:$96.17K

SUSQUEHANNA INTERNATIONAL GROUP, LLP
Shares:397.91K
Value:$71.94K
Summary
Showing Top 3 of 35
About ProPhase Labs, Inc.
https://www.prophaselabs.comProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $883K ▼ | $4.64M ▲ | $-6.84M ▼ | -774.52% ▼ | $-1.6 ▼ | $-4.39M ▼ |
| Q2-2025 | $1.25M ▼ | $4.63M ▲ | $-4.47M ▼ | -358.62% ▼ | $-1.1 ▼ | $-3.57M ▼ |
| Q1-2025 | $1.43M ▲ | $4.19M ▼ | $3.97M ▲ | 277.15% ▼ | $2.1 ▲ | $-2.54M ▲ |
| Q4-2024 | $-2.48M ▼ | $15.49M ▲ | $-34.36M ▼ | 1.38K% ▲ | $-15.8 ▼ | $-14.32M ▼ |
| Q3-2024 | $3.15M | $7.77M | $-6.59M | -209.38% | $-3.5 | $-5.43M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $405K ▲ | $65.7M ▲ | $58.84M ▲ | $6.86M ▼ |
| Q2-2025 | $171K ▲ | $42.04M ▼ | $30.61M ▼ | $11.44M ▼ |
| Q1-2025 | $88K ▼ | $50.59M ▼ | $34.99M ▼ | $15.6M ▲ |
| Q4-2024 | $678K ▼ | $63.2M ▼ | $55.85M ▲ | $7.35M ▼ |
| Q3-2024 | $1.1M | $91.81M | $53.68M | $38.13M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-6.84M ▼ | $-21.52M ▼ | $-920K ▼ | $3.72M ▲ | $236K ▲ | $-21.52M ▼ |
| Q2-2025 | $-4.47M ▲ | $-247K ▲ | $67K ▼ | $261K ▼ | $81K ▲ | $-247K ▲ |
| Q1-2025 | $-4.68M ▲ | $-3.38M ▼ | $853K ▲ | $1.94M ▼ | $-590K ▼ | $-3.38M ▼ |
| Q4-2024 | $-30.52M ▼ | $2.16M ▲ | $-40K ▲ | $3.73M ▲ | $-416K ▲ | $2.4M ▲ |
| Q3-2024 | $-6.59M | $-4.03M | $-97K | $2.86M | $-1.27M | $-4.21M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Consumer Products Segment | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Consumer Products | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |

CEO
Ted William Karkus
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-12-22 | Reverse | 1:10 |
| 1997-01-23 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : D+
Price Target
Institutional Ownership

SYKON CAPITAL LLC
Shares:644.79K
Value:$116.58K

VANGUARD GROUP INC
Shares:531.92K
Value:$96.17K

SUSQUEHANNA INTERNATIONAL GROUP, LLP
Shares:397.91K
Value:$71.94K
Summary
Showing Top 3 of 35


